Dow Up1.63% Nasdaq Up0.97%

Peregrine Pharmaceuticals, Inc. (PPHM)

1.49 0.05(3.47%) Oct 17, 4:00PM EDT
Insider TransactionsGet Insider Transactions for:
Net Share Purchase Activity
Insider Purchases - Last 6 Months
Net Shares Purchased
Total Insider Shares Held12.47MN/A
% Net Shares Purchased
Net Institutional Purchases - Prior Qtr to Latest Qtr
Net Shares Purchased
% Change in Institutional Shares Held(8.4%)
Data provided by Thomson Financial

Insider Transactions Reported - Last Two Years
Apr 30, 2014FUSSEY SHELLEY PMOfficer6,571DirectAcquisition (Non Open Market) at $1.11 per share.7,293
Apr 30, 2014KING STEVEN WOfficer4,020DirectAcquisition (Non Open Market) at $1.11 per share.4,462
Apr 29, 2014KING STEVEN WOfficer25,662DirectDisposition (Non Open Market) N/A
Oct 31, 2013KING STEVEN WOfficer4,131DirectAcquisition (Non Open Market) at $1.08 per share.4,461
Oct 31, 2013FUSSEY SHELLEY PMOfficer6,752DirectAcquisition (Non Open Market) at $1.08 per share.7,292
Oct 15, 2013KING STEVEN WOfficer100,000DirectAcquisition (Non Open Market) N/A
Apr 30, 2013KING STEVEN WOfficer6,516DirectAcquisition (Non Open Market) at $0.71 per share.4,626
Apr 30, 2013LYTLE PAUL JOfficer11,988DirectAcquisition (Non Open Market) at $0.71 per share.8,511
Apr 30, 2013FUSSEY SHELLEY PMOfficer10,481DirectAcquisition (Non Open Market) at $0.71 per share.7,441
Oct 31, 2012KING STEVEN WOfficer11,000DirectAcquisition (Non Open Market) at $0.39 per share.4,290
Oct 31, 2012FUSSEY SHELLEY PMOfficer17,980DirectAcquisition (Non Open Market) at $0.39 per share.7,012
Oct 31, 2012LYTLE PAUL JOfficer20,885DirectAcquisition (Non Open Market) at $0.39 per share.8,145
Data provided by EDGAR Online
* = Where indicated, some values are estimates.
1= Potential proceeds estimated by the filer.
2= Estimated based on the average of multiple prices reported.
3= Multiple dates reported. Most recent date shown.

Currency in USD.

All Major Holders - Insider Roster